Individuals with pathogenic germline STK11 variants have a lifelong elevated risk to acquire various types of malignancies, such as gastrointestinal, pancreatic, testicular, cervical and breast cancer, that mainly manifest themselves during adulthood (26–28). Here, STK11 is linked to breast cancer.